Ethics of Insurance-driven Barriers to Biologic Therapy in Hidradenitis Suppurativa

Letter/Communication

Esther Nwozo, Chiebuka Onuoha and Nicole A Negbenebor

Journal of the American Academy of Dermatology, Vol.95(2), pp.e105-e106

08/2026

DOI: 10.1016/j.jaad.2026.02.121

PMID: 41791512

View Online

no abstract

Medical Ethics

Hidradenitis suppurativa

Psoriasis

Inflammatory disorders

Health equity

Medicaid

Insurance prior authorization

Biologic therapy

Title: Subtitle: Ethics of Insurance-driven Barriers to Biologic Therapy in Hidradenitis Suppurativa
Creators: Esther Nwozo - Temple University
Chiebuka Onuoha - Temple University
Nicole A Negbenebor - University of Iowa
Resource Type: Letter/Communication
Publication Details: Journal of the American Academy of Dermatology, Vol.95(2), pp.e105-e106
DOI: 10.1016/j.jaad.2026.02.121
PMID: 41791512
NLM abbreviation: J Am Acad Dermatol
ISSN: 1097-6787
eISSN: 1097-6787
Publisher: Elsevier
Language: English
Electronic publication date: 03/04/2026
Date published: 08/2026
Academic Unit: Dermatology
Record Identifier: 9985141898002771

4 Record Views